What is PACS's health score?

PACS Group, Inc. (PACS) has a TradeApes health score of 66 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is PACS's estimated fair value?

Based on our 5-year discounted cash flow model, PACS Group, Inc.'s estimated fair value is $76.78 per share, representing a 110.4% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is PACS undervalued or overvalued?

Our model currently rates PACS as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for PACS... Refresh in a moment for the full analysis.

PACS Group, Inc. (PACS)

Healthcare Undervalued low healthy

$36.5

Updated: 2026-06-03

TradeApes Score

Financial Strength

65 Healthy

Operating Trend

65 Healthy

Relative Value

65 Healthy

Capital Allocation

70 Healthy

Risk

70 Healthy

Est. Fair Value $76.78

DCF Upside +110.4%

Sector Rank #220 of 6790

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Weak liquidity — current assets below current liabilities

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.